J. LAVIZZO MOUREY - 28 Oct 2021 Form 4 Insider Report for Better Therapeutics, Inc.

Role: Director
Signature: /s/ Mark Heinen, Attorney-in-Fact for Risa J. Lavizzo-Mourey
Issuer symbol: BTTX on OTC
Transactions as of: 28 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 01 Nov 2021, 20:55:05 UTC
Previous filing: 26 Oct 2021
Next filing: 23 Dec 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTTX	Stock Option (Right to Buy)	Award	$0	+28,300		$0.000000	28,300	28 Oct 2021	Common Stock	28,300	$10.97	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.

Content

Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.